Renvela Related Clinical Trials
The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan [Recruiting]
Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients [Recruiting]
Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD) [Recruiting]
FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease [Recruiting]
An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients With Chronic Kidney Disease [Recruiting]
Sevelamer Hydrochloride in Peritoneal Dialysis Patients [Recruiting]
Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease [Recruiting]
The Effects of Sevelamer Carbonate on Diabetic Nephropathy [Recruiting]
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients [Recruiting]
Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate [Not yet recruiting]
Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy [Recruiting]
Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease [Recruiting]
Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4 [Recruiting]
FGF-23 Regulation in Chronic Kidney Disease [Not yet recruiting]
Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis [Recruiting]
Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease [Recruiting]
A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients [Recruiting]
A 58-Week Safety and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-stage Renal Disease (ESRD) on Dialysis [Not yet recruiting]
A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD [Recruiting]
Hypophosphatemic Rickets in Norway [Recruiting]
A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease [Recruiting]
Pulmonary Hypertension Prevention in Hemodialysis [Not yet recruiting]
|
